Bacterial pathogens and disease Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Define pathogen, pathogenicity, virulence, toxigenicity

A

Pathogen: A microorganism capable of causing disease

Pathogenicity: The ability of an infectious agent to cause disease

Virulence: the quantitative ability of an agent to cause disease

Toxigenicity: the ability of a microorganism to produce a toxin that contributes to the development of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What mechanisms give virulence to bacteria?

A

Adherence factors, proteins and molecules that allow bacteria to attach to surface

Biofilm, allows bacteria to produce 3D communities and structures

Invasion of host cells and tissues, allowed by mechanisms – allows colonisation

Toxins – endotoxins and exotoxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are exotoxins?

A

Heterogenous group of proteins produced and secreted by living bacterial cells

Produced by both gram negative and gram-positive bacteria

NOT the result of breakdown products, produced by living bacteria.

Cause disease symptoms in host during disease

Act via a variety of diverse mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What selective advantage does having exotoxins give to the bacteria?

A

Cause disease? May help transmission of disease by promoting carriage, however in severe disease host may be a literal and evolutionary dead end.

Evade immune response

Enable biofilm formation

Enable attachment to host cells

Escape from phagosomes

allow for colonisation, niche estabilishment and carriage - evolutionary advantage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do exotoxins produce in the case of staphylococcus aureus?

A

Haemolytic toxins

  • Cause cells to lyse by forming pores on the membrane
  • Important cause of features of S.Aureus disease
  • a, B, Y toxins, Panton Valentine leukocidin (PVL), LukAB, LukEF, LukMF

Phenol soluble modulins PSM

  • Aggregate the lipid bilayer of host cells – causes cell lysis, damages lipid bilayer

Majority of S.aureus in humans is asymptomatic carriage in the nose and respiratory tract, and skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does PSM help bacteria, starting cell cell phagocytososing bacteria

A

A. Cell, phagocytosing bacteria. PSMs allow bacteria to escape from phagosome. Alpha toxins block the binding of lysosomes to the phagosome, avoiding the destruction by acidification and enzymes released by lysosomes.

B. PSM useful at helping S.aureus in displacing other bacteria in the environment. By killing all the bacteria, it can find a niche and be dominant.

C. S.Aureus releases PSM as it allows it to slide through certain media like throats and mucosal sites.

D. Alpha toxins, beta toxins and PSM help initiate formation of biofilms, a community of bacteria that first need to find a niche and attach, accumulate and then interact with other molecules and different organisms to form a secondary structure.

Alpha and beta toxins allow this process. PSM helps chunks of that biofilm move and aids carriage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What can exotoxins be encoded by?

A

Encoded by chromosomal genes Shiga toxin in Shigella dysenteriae, TcdA and TcdB in C.difficle.

Many toxins coded by extrachromosomal genes :

  • Plasmids – Bacillus anthracis toxin, tetanus toxin
  • Lysogenic bacteriophage (viruses of bacteria) – e.g streptococcal pyrogenic exotoxins in Scarlet Fever, Diphtheria toxin

toxins can be transferred, species that could not cause disease now cause disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Toxins can be classified by the toxins activity

What are the issues with this classification?

A
  1. Membrane acting toxins – type 1
  2. Membrane damaging toxins – type 2
  3. Intracellular toxins – type 3

2.

Many toxins may have more than one type of activity

As mechanisms better understood by this classification tends to break down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where do type 1, mechanism activating toxins:

Act

Interfere

Target

A

Act:

  • Act from without the cell

Interfere:

  • Interfere with the host cell signalling by inappropriate activation of host cell receptors

Target:

Target receptors include

  • Guanylyl cyclase – increased intracellular cGMP
  • Adenyl cyclase – increased intracellular cAMP
  • Rho proteins
  • Ras proteins

acting on cGMP and cAMP messes up central signalling pathways of host cells + conserved pathways, potential to cause severe diseases as most cells rely on production of cGMP and cAMP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do type 2, membrane damaging toxins cause damage to the host cell membrane?

A

1.

  • Insert channels into the host cell membrane, disrupting the potential and transport of ions
  • Beta sheet toxins e.g S.aureus a-toxin, y toxin, PVL
  • Alpha helix toxins e.g diphtheria toxin
  1. Enzymatical damage that damages the cell e.g S.aureus Beta – haemolysin, PSM

Or

  1. Receptor mediated
  2. Receptor independent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where are intracellular toxins, type 3 active?

What two components is it made of?

A
  1. Active within the cell – must gain access to the cell

Usually 2 components – AB toxins

  • Receptor binding and translocation function – B
  • Toxigenic (enzymatic) - A
  • May be single or multiple B units e.g Cholera toxin AB5 – 5 B subunits.

Component B is the one that binds to the cell surface receptor to allow for internalisation of the toxin.

A is toxic and has enzymatic activity or tampers with metabolism of the cell – acts within cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Enzymatic component A of type 3 toxins has a wide variety of activities

A

ADP – ribsoyl transferases e.g Exotoxin A of Pseudomonas aeruginosa, pertussis toxin

Glucosyltransferases e.g TcdA and TcdB of Clostridium difficile

Deamidase e.g dermonecrotic toxin of Bordetella pertussis

Protease e.g Clostridial neurotoxins: botulism and tetanus

Adenylcyclase e.g EF (edema factor) toxin Bacillus antrhacis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bacteria have different types of secretory mechanisms

Give examples

A

Secretions

And toxin injections

Multi-molecule complexes that act like needles.

Can have multi-meric secretory system, a pump of toxins like toxin CagA in Heliobacter pylori

On the left is an inner and outer membrane of a cell, a subunit protrudes and interacts with the host membrane to inject toxin.

e.g YopE in Yersinia species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do exotoxins induce the release of?

A

Induce release of inflammatory cytokines

IL1, IL1B(beta), TNF, IL6, interferon y, IL18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do supernatigens interact with the immune system and cause disease?

A

Superantigen: non-specific bridging of the MHC class II and T-cell receptor leading to cytokine production

e.g Staphyloccal Exfoliative Toxin A, toxic Shock Syndrome Toxin I (TSST1)

Via activation of the different inflammasome leading to release of IL1 Beta and IL18 e.g S.aureus toxin A, PVL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What happens when exotoxins bypass antigen presentation and cause clonal activation?

A

Bypass and crosslink the MHC to the T-cell receptor, do this regardless of the specificity of the MHC peptide complex and T cell receptor.

Consequence of this that it produces activation of many different clones.

Leads to a huge inflammatory response, a great amount of cytokine production, and then induce toxic shock.

example of this is Staphlyococcal toxins that cause this, transmitted through tampons – difficult to treat and can lead to fatality so not always beneficial to toxin.

17
Q

Toxins can be supernatigens or inflammasome, what is an inflammasome?

A

Inflammasome is complex set of pathways, able to detect infection or damage, leading onto maturation and production of cytokines – leading to an immune response.

18
Q

How can toxins be inactivated?

What are toxoids?

A
  1. Toxins can be inactivated using formaldehyde or glutaraldehyde – toxoids
  2. Toxoids are inactive proteins but still highly immunogenic – form the basis of vaccines
  • Tetanus vaccine
  • Diphtheria
  • Pertussis (acellular)
19
Q

How is toxin mediated disease treated?

A

By adminstering performed antibodies to the toxin

  • Diptheria antitoxin – horse antibodies
  • Tetanus – pooled human immunoglobulin. Specific or normal
  • Botulism – horse antibodies
  • Experimental and research – monoclonal antibodies

antibodies don’t have function in immune system but block toxin.

20
Q

Describe the microbiology of clostridium difficile disease

A

Gram-positive bacillus

Anaerobic

Spore-forming – produces spores that are resistant to specific environments etc so can transmit easily

Toxin-producing – like TcdA and TcdB

Can be carried asymptomatically in gut

3 toxins

21
Q

What is the epidemiology of c.difficle?

A

Common hospital acquired infection worldwide

Spread by ingestion of spores – remain dormant in environment

Coloniser of the human gut up to 5% in adults – some of those patients need risk factors to develop the disease

Risk factors – antibiotic use, age, antacids and prolonged hospital stay

22
Q

How do antibiotics treat c.difficle?

A
  • Act by disrupting the microbial ecosystem within gut
  • Antibiotics provide a competitive advantage to spore forming anaerobes over non-spore forming anaerobes
  • Allows C.difficile colonisation and growth
  • All antibiotics have potential for causing disease

Some antibiotics worse than others

  • 2nd and 3rd generation cephalosporins
  • Quinolones
  • Clindamycin ? - not clear

Others less likely

  • Aminoglycosides
  • Trimethoprim
  • Vancomycin
23
Q

What is the pathogenesis of C.difficile?

What two effects does GTD binding to Rho GTPases lead to?

A

Receptor binding domain binds to receptor, toxin internalised

Endosome acidifies, allows for increase in activity of CPD (cysteine protease domain)

and interaction of DD (delivery hydrophobic domain) allows for the release of the toxin from the endosome

GTD (glucotransferase domain) released from the endosome to the host cell cytoplasm thanks to protease activity of CPD

Binds to Rho GTPases, leading onto two effects

  • Cytopathic effects – cytoskeleton breakdown, loss of cell-cell contacts, increased epithelial permeability - and other functions that depend on cytoskeleton like renewal of cells, division of stem cells etc. Prolonged damage.
  • Cytotoxic effects – activation of the inflammasome, increase in ROS levels (causes bystander damage) , induction of programmed cell death
24
Q

What is seen in the gut of someone with c.difficile disease?

A
  • Patchy necrosis with neutrophil infiltration
  • Epithelial ulcers
  • Pseduomembranes – leucocytes, fibrin, mucous, cell debris

Starts asymptomatic, many of us can carry C.difficile without having a problem if it’s not predominant

When it starts producing symptoms it produces watery diarrhoea

Induces Pseudomembranous Colitis

Some circumstances it can lead onto toxic megacolon and peritonitis – fecal matter enters peritoneal cavity and we end up with peritonitis

25
Q

How is C.difficle diagnosed?

What does the 2 phase test include?

A

Clinical signs and symptoms – watery diarrhoea

Raised white cell count in blood

Detection of organisms and toxins in stool

2 phase test

  1. Glutamate dehydrogenase – detects if C.difficile organism is present
  2. Toxin enzyme linked immunosorbent assay (ELISA) for TcdA and TcdB toxins

Detection of tcdA and tcdB genes – PCR

Colonoscopy – psuedomembranous colitis

26
Q

How is C.diffcile disease treated?

A

Dependent on severity and presence of surgical complications

Ideally removal of offending antibiotic – not always possible

Antibiotics fidaxomicin or metronidazole or vancomycin

Surgery – partial, total colectomy

Recurrent – faceal transplant

27
Q

What disease can verocytotoxin Edcherichia coli cause?

A

VTEC or shiga-toxin (stx) producing E.coli (STEC) can cause disease, mild to life threatening

Stx carried by some E.coli - most commonly 0.157:H7

  • Identified usually by growth on sorbitol MacConkey agar (SMac) - does not ferment sorbitol and hence is clear
  • Other less common types not identified using Smac
28
Q

Where does E.coli naturally colonise?

How is it transmitted?

A

E.coli O157:H7 naturally colonises the gastrointestinal tracts of cattle who are generally asymptomatic

Transmission

  • Predominantly via consumption of contaminated food and water
  • Person to person, particularly in child day-care facilities
  • Animal to person e.g in petting zoos, farms or camp groups

Very low infectious dose

29
Q

What is the pathogenesis of the Shigatoxin and verocytotoxin?

Gene carried on

Type of exotoxin

Enzymatic components A and B

A

Toxin – Shiga like toxin (SLT) = shigatoxin (Stx) = verocytotoxin (VTEC)

Stx, Stx1, Stx1a, 1c, 1d, Stx2a, 2c 2d – variations in a.a sequence

Gene carried on lysogenic virus

Type III exotoxin – AB5

Enzymatic component A = N-Glycosidase

Bound to 5 B subunits

30
Q

What is the mechanism of Stx and VTEC?

A

Binds to receptor globo-tri-aosyl-ceramide Gb3 or globo-tetra-osyl-ceramide (Gb4) on host cell membrane

Bound toxin internalised by receptor mediated endocytosis

Carried by retrograde trafficking via the golgi apparatus to the endoplasmic reticulum

The A subunit is cleaved off by membrane bound proteases

Once in the cytoplasm A1 and A2 disassociated

A1 binds to 28S RNA subunit – blocks protein synthesis

31
Q

STEC pathogenesis

What cells does it to adhere to?

Where are there high levels of Gb3

What does Stx favour

A

STEC closely adheres to the epithelial cells of the gut mucosa

The route by which Stx transported from the intestine to the kidney and other tissues is debated, possible polymorphonuclear neutrophils (PMNs)

Bind to the glomerular endothelial cells of kidney, cardiovascular and central nervous system - high levels of Gb3 in kidney so kidneys most affected

Stx favours inflammation resulting in microvascular thrombosis and inhibition of fibrinolysis

32
Q

What are the symptoms of STEC disease?

Who is at greatest risk?

A

Can be severe and life threatening

Children <5 years at greatest risk

Abdominal cramps, watery or bloody diarrhoea – may not be present

Haemolytic uraemic syndrome

  • Anaemia
  • Renal failure
  • Thrombocytopaenia

Less common are neurological symptoms

  • Lethargy
  • Severe headache
  • Convulsions
  • Encephalopathy
33
Q

How is STEC diagnosed?

A

Clinical signs and symptoms

Haematological and biochemical evidence

Stool culture – growth on SMac

PCR for stx genes

34
Q

How is STEC treated?

A

Supportive including renal dialysis and blood product transfusion

Antibiotics have little to no role

Difficult to treat

35
Q
A